Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases


Por: Liu Z, Ezzedine N, Eterovic A, Ensor J, Huang H, Albanell J, Choi D, Lluch A, Liu Y, Rojo F, Wong H, Martinez-Duenas E, Guerrero-Zotano A, Shao Z, Darcourt J, Mills G, Dave B, Chang J

Publicada: 1 nov 2019
Resumen:
Purpose Limited knowledge exists on the detection of breast cancer stem cell (BCSC)-related mutations in circulating free DNA (cfDNA) from patients with advanced cancers. Identification of new cancer biomarkers may allow for earlier detection of disease progression and treatment strategy modifications. Methods We conducted a prospective study to determine the feasibility and prognostic utility of droplet digital polymerase chain reaction (ddPCR)-based BCSC gene mutation analysis of cfDNA in patients with breast cancer. Results Detection of quantitative BCSC gene mutation in cfDNA by ddPCR mirrors disease progression and thus may represent a valuable and cost-effective measure of tumor burden. We have previously shown that hematological and neurological expressed 1-like (HN1L), ribosomal protein L39 (RPL39), and myeloid leukemia factor 2 (MLF2) are novel targets for BCSC self-renewal, and targeting these genetic alterations could be useful for personalized genomic-based therapy. Conclusion BCSC mutation detection in cfDNA may have important implications for diagnosis, prognosis, and serial monitoring.

Filiaciones:
Liu Z:
 Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 20032, Peoples R China

 Houston Methodist Res Inst, Houston, TX 77030 USA

 Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China

Ezzedine N:
 Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA

 Univ Texas MD Anderson Canc Ctr, Inst Personalized Canc Therapy, Houston, TX 77030 USA

Eterovic A:
 Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA

 Univ Texas MD Anderson Canc Ctr, Inst Personalized Canc Therapy, Houston, TX 77030 USA

Ensor J:
 Houston Methodist Canc Ctr, 6445 Main St P21-34, Houston, TX 77030 USA

Huang H:
 Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Houston, TX 77030 USA

Albanell J:
 GEICAM Spanish Breast Canc Grp, Madrid 28703, Spain

 ISCIII, CIBERONC, Ctr Invest Biomed Red Oncol, Madrid 28029, Spain

 Hosp del Mar, Barcelona 08003, Spain

Choi D:
 Houston Methodist Res Inst, Houston, TX 77030 USA

 Houston Methodist Canc Ctr, 6445 Main St P21-34, Houston, TX 77030 USA

Lluch A:
 GEICAM Spanish Breast Canc Grp, Madrid 28703, Spain

 ISCIII, CIBERONC, Ctr Invest Biomed Red Oncol, Madrid 28029, Spain

 Hosp Clin Univ Valencia, Valencia 46010, Spain

Liu Y:
 Houston Methodist Res Inst, Houston, TX 77030 USA

 Houston Methodist Canc Ctr, 6445 Main St P21-34, Houston, TX 77030 USA

Rojo F:
 GEICAM Spanish Breast Canc Grp, Madrid 28703, Spain

 ISCIII, CIBERONC, Ctr Invest Biomed Red Oncol, Madrid 28029, Spain

 Fdn Jimenez Diaz, E-28040 Madrid, Spain

Wong H:
 Houston Methodist Res Inst, Houston, TX 77030 USA

 Houston Methodist Canc Ctr, 6445 Main St P21-34, Houston, TX 77030 USA

Martinez-Duenas E:
 GEICAM Spanish Breast Canc Grp, Madrid 28703, Spain

 Hosp Prov Castellon, Castellon de La Plana 12002, Spain

Guerrero-Zotano A:
 GEICAM Spanish Breast Canc Grp, Madrid 28703, Spain

 Inst Valenciano Oncol, Valencia 46009, Spain

Shao Z:
 Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 20032, Peoples R China

Darcourt J:
 Houston Methodist Canc Ctr, 6445 Main St P21-34, Houston, TX 77030 USA

Mills G:
 Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA

 Univ Texas MD Anderson Canc Ctr, Inst Personalized Canc Therapy, Houston, TX 77030 USA

Dave B:
 Houston Methodist Res Inst, Houston, TX 77030 USA

 Houston Methodist Canc Ctr, 6445 Main St P21-34, Houston, TX 77030 USA

Chang J:
 Houston Methodist Res Inst, Houston, TX 77030 USA

 Houston Methodist Canc Ctr, 6445 Main St P21-34, Houston, TX 77030 USA
ISSN: 01676806





BREAST CANCER RESEARCH AND TREATMENT
Editorial
Kluwer Academic Publishers, 233 SPRING ST, NEW YORK, NY 10013 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 178 Número: 2
Páginas: 251-261
WOS Id: 000491200400001
ID de PubMed: 31388936

MÉTRICAS